TrialmAbs
ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Sophie Dupuis-Girod et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
pooled ittrialcites it